From left: Sonja Connor, M.S., R.D., L.D., professor emeritus; Igor Landais, Ph.D., VGTI quality system director; Andrea DeBarber, Ph.D.; and Maya Fowler, assistant core scientist. Researchers at OHSU discovered biomarkers essential to identifying and treating the disease, which led to a clinical trial at OHSU that in February culminated in FDA approval of an effective treatment for patients. (OHSU/Christine Torres Hicks)

Gladis Reyes Pimentel, core scientist, works in the DeBarber lab. Researchers at OHSU discovered biomarkers essential to identifying and treating the disease CTX, which led to a clinical trial at OHSU that in February culminated in FDA approval of an effective treatment for patients. (OHSU/Christine Torres Hicks)